Trial intelligence / Profile preview

Linifanib + Paclitaxel in Metastatic Breast Cancer

NCT00645177Phase 2Completed

Sponsor
AbbVie Inc.
Start
Jul 2008
Primary completion
Dec 2009
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of linifanib in breast cancer, sponsored by AbbVie Inc.. Started Jul 2008; status: completed.

02

Drugs

linifanib
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT00645177.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00645177.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call